Updates are available Correction dated 2025-05-16
Click to view Correction: https://doi.org/10.1007/s10120-025-01625-7
-
Authors
Tay, Ryan Yong Kiat
Sachdeva, Manavi
Ma, Haoran
Kim, Young-Woo
Kook, Myeong-Cherl
Kim, Hyunki
Cheong, Jae-Ho
Hewitt, Lindsay C.
Nekolla, Katharina
Schmidt, Günter
Yoshikawa, Takaki
Oshima, Takashi
Arai, Tomio
Srivastava, Supriya
Teh, Ming
Ong, Xuewen
Tay, Su Ting
Sheng, Taotao
Zhao, Joseph J.
Tan, Patrick
Grabsch, Heike I.
Sundar, Raghav https://orcid.org/0000-0001-9423-1368
-
Funding
Funding for this research was provided by:
National University Health System Seed Fund (NUHSRO/2024/008/RO5+6/Seed-Sep23/01)
Clinician Scientist Development Unit (CSDU) NUS Medicine Student Research Mentorship Program
National University Hospital Junior Research Award (JRA/Sep23/002)
Chan Heng Leong Education & Research Fund
Dean's Research Development Award
National Medical Research Council (MOH-OFLCG18May-0003)
National Medical Research Council (MOH-000967)
National Medical Research Council (NMRC/CIRG23Jul-0035)
National Medical Research Council (NMRC/ MOH-000627)
Leeds Biomedical Research Centre
- License Information
-
More Information
Article History
Received: 18 September 2024
Accepted: 20 January 2025
First Online: 19 February 2025
Change Date: 15 May 2025
Change Type: Update
Change Details: The original online version of this article was revised to add a co-author ‘Katharina Nekolla’.
Change Date: 16 May 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10120-025-01625-7
Declarations
:
: P. T reports other support from Tempus Healthcare outside the submitted work. RS reports other support from Bristol Myers Squibb, Merck, Eisai, Bayer, Taiho, Novartis, Eli Lilly, Roche, AstraZeneca, DKSH, MSD, Paxman Coolers, Natera, Astellas, GSK, Ipsen, Pierre-Fabre, Tavotek, Sanofi, Daichii Sankyo, Beigene, CytoMed and Auristone outside the submitted work.
